The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antibacterial Active Peptide Market Research Report 2024
Synopsis
Antimicrobial peptides, also known as host defense peptides, are a class of basic polypeptide substances with antibacterial activities related to innate immunity. Antimicrobial peptides have antifungal, antitumor, and antiviral activities, and have the advantages of good thermal stability and specificity. They have good application prospects in the fields of medicine, health care products, agricultural product preservation, feed, and breeding.
The global Antibacterial Active Peptide market was valued at US$ 7198 million in 2023 and is anticipated to reach US$ 12910 million by 2030, witnessing a CAGR of 8.6% during the forecast period 2024-2030.
Antimicrobial peptides can rapidly kill many microorganisms, including bacteria, fungi, viruses and tumor cells, especially those pathogens that are resistant to multiple antibiotics. Unlike antibiotics that inhibit or kill microorganisms, antimicrobial peptides can kill or inhibit pathogens through a variety of mechanisms, including acting on pathogen cell membranes, maintaining the body's intestinal health, enhancing the body's immunity, and regulating host inflammatory responses. Antimicrobial peptides are widely used in the market. In agriculture, they can be used as feed additives and are suitable for raising various animals. In medicine, they can be used as excellent substitutes for antibiotics, and are also considered to be promising drugs that can overcome cancer and AIDS in the future; In industry, it can be used as a green preservative; in human life, it can be used as a substitute for health care products and antibacterial substances. With the continuous improvement of the economy and living standards, people will pay more and more attention to their own health, and the demand for antimicrobial peptides will continue to increase.
This report aims to provide a comprehensive presentation of the global market for Antibacterial Active Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibacterial Active Peptide.
Report Scope
The Antibacterial Active Peptide market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibacterial Active Peptide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibacterial Active Peptide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lytix Biopharma AS
Genscript
Biosynth Carbosynth
CPC Scientific
Peptilogics, Inc.
MaxWell Biosciences
ContraFect Corporation
Lytica Therapeutics , Inc.
Amprologix
Ingenza
ReAlta Life Sciences
Celdara Medical
Numaferm
ALLVIVO VASCULAR, INC.
Matrubials
Segment by Type
Microbial Antimicrobial Peptides
Plant Antimicrobial Peptides
Animal Antimicrobial Peptides
Others
Segment by Application
Food
Medical
Animal Food
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antibacterial Active Peptide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Antibacterial Active Peptide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Antibacterial Active Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Antimicrobial peptides, also known as host defense peptides, are a class of basic polypeptide substances with antibacterial activities related to innate immunity. Antimicrobial peptides have antifungal, antitumor, and antiviral activities, and have the advantages of good thermal stability and specificity. They have good application prospects in the fields of medicine, health care products, agricultural product preservation, feed, and breeding.
The global Antibacterial Active Peptide market was valued at US$ 7198 million in 2023 and is anticipated to reach US$ 12910 million by 2030, witnessing a CAGR of 8.6% during the forecast period 2024-2030.
Antimicrobial peptides can rapidly kill many microorganisms, including bacteria, fungi, viruses and tumor cells, especially those pathogens that are resistant to multiple antibiotics. Unlike antibiotics that inhibit or kill microorganisms, antimicrobial peptides can kill or inhibit pathogens through a variety of mechanisms, including acting on pathogen cell membranes, maintaining the body's intestinal health, enhancing the body's immunity, and regulating host inflammatory responses. Antimicrobial peptides are widely used in the market. In agriculture, they can be used as feed additives and are suitable for raising various animals. In medicine, they can be used as excellent substitutes for antibiotics, and are also considered to be promising drugs that can overcome cancer and AIDS in the future; In industry, it can be used as a green preservative; in human life, it can be used as a substitute for health care products and antibacterial substances. With the continuous improvement of the economy and living standards, people will pay more and more attention to their own health, and the demand for antimicrobial peptides will continue to increase.
This report aims to provide a comprehensive presentation of the global market for Antibacterial Active Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibacterial Active Peptide.
Report Scope
The Antibacterial Active Peptide market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibacterial Active Peptide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibacterial Active Peptide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lytix Biopharma AS
Genscript
Biosynth Carbosynth
CPC Scientific
Peptilogics, Inc.
MaxWell Biosciences
ContraFect Corporation
Lytica Therapeutics , Inc.
Amprologix
Ingenza
ReAlta Life Sciences
Celdara Medical
Numaferm
ALLVIVO VASCULAR, INC.
Matrubials
Segment by Type
Microbial Antimicrobial Peptides
Plant Antimicrobial Peptides
Animal Antimicrobial Peptides
Others
Segment by Application
Food
Medical
Animal Food
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antibacterial Active Peptide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Antibacterial Active Peptide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Antibacterial Active Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Antibacterial Active Peptide Market Overview
1.1 Product Definition
1.2 Antibacterial Active Peptide Segment by Type
1.2.1 Global Antibacterial Active Peptide Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Microbial Antimicrobial Peptides
1.2.3 Plant Antimicrobial Peptides
1.2.4 Animal Antimicrobial Peptides
1.2.5 Others
1.3 Antibacterial Active Peptide Segment by Application
1.3.1 Global Antibacterial Active Peptide Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Food
1.3.3 Medical
1.3.4 Animal Food
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Antibacterial Active Peptide Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Antibacterial Active Peptide Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Antibacterial Active Peptide Production Estimates and Forecasts (2019-2030)
1.4.4 Global Antibacterial Active Peptide Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Antibacterial Active Peptide Production Market Share by Manufacturers (2019-2024)
2.2 Global Antibacterial Active Peptide Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Antibacterial Active Peptide, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Antibacterial Active Peptide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Antibacterial Active Peptide Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Antibacterial Active Peptide, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Antibacterial Active Peptide, Product Offered and Application
2.8 Global Key Manufacturers of Antibacterial Active Peptide, Date of Enter into This Industry
2.9 Antibacterial Active Peptide Market Competitive Situation and Trends
2.9.1 Antibacterial Active Peptide Market Concentration Rate
2.9.2 Global 5 and 10 Largest Antibacterial Active Peptide Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Antibacterial Active Peptide Production by Region
3.1 Global Antibacterial Active Peptide Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Antibacterial Active Peptide Production Value by Region (2019-2030)
3.2.1 Global Antibacterial Active Peptide Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Antibacterial Active Peptide by Region (2025-2030)
3.3 Global Antibacterial Active Peptide Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Antibacterial Active Peptide Production by Region (2019-2030)
3.4.1 Global Antibacterial Active Peptide Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Antibacterial Active Peptide by Region (2025-2030)
3.5 Global Antibacterial Active Peptide Market Price Analysis by Region (2019-2024)
3.6 Global Antibacterial Active Peptide Production and Value, Year-over-Year Growth
3.6.1 North America Antibacterial Active Peptide Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Antibacterial Active Peptide Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Antibacterial Active Peptide Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Antibacterial Active Peptide Production Value Estimates and Forecasts (2019-2030)
4 Antibacterial Active Peptide Consumption by Region
4.1 Global Antibacterial Active Peptide Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Antibacterial Active Peptide Consumption by Region (2019-2030)
4.2.1 Global Antibacterial Active Peptide Consumption by Region (2019-2024)
4.2.2 Global Antibacterial Active Peptide Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Antibacterial Active Peptide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Antibacterial Active Peptide Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Antibacterial Active Peptide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Antibacterial Active Peptide Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Antibacterial Active Peptide Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Antibacterial Active Peptide Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Antibacterial Active Peptide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Antibacterial Active Peptide Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Antibacterial Active Peptide Production by Type (2019-2030)
5.1.1 Global Antibacterial Active Peptide Production by Type (2019-2024)
5.1.2 Global Antibacterial Active Peptide Production by Type (2025-2030)
5.1.3 Global Antibacterial Active Peptide Production Market Share by Type (2019-2030)
5.2 Global Antibacterial Active Peptide Production Value by Type (2019-2030)
5.2.1 Global Antibacterial Active Peptide Production Value by Type (2019-2024)
5.2.2 Global Antibacterial Active Peptide Production Value by Type (2025-2030)
5.2.3 Global Antibacterial Active Peptide Production Value Market Share by Type (2019-2030)
5.3 Global Antibacterial Active Peptide Price by Type (2019-2030)
6 Segment by Application
6.1 Global Antibacterial Active Peptide Production by Application (2019-2030)
6.1.1 Global Antibacterial Active Peptide Production by Application (2019-2024)
6.1.2 Global Antibacterial Active Peptide Production by Application (2025-2030)
6.1.3 Global Antibacterial Active Peptide Production Market Share by Application (2019-2030)
6.2 Global Antibacterial Active Peptide Production Value by Application (2019-2030)
6.2.1 Global Antibacterial Active Peptide Production Value by Application (2019-2024)
6.2.2 Global Antibacterial Active Peptide Production Value by Application (2025-2030)
6.2.3 Global Antibacterial Active Peptide Production Value Market Share by Application (2019-2030)
6.3 Global Antibacterial Active Peptide Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Lytix Biopharma AS
7.1.1 Lytix Biopharma AS Antibacterial Active Peptide Corporation Information
7.1.2 Lytix Biopharma AS Antibacterial Active Peptide Product Portfolio
7.1.3 Lytix Biopharma AS Antibacterial Active Peptide Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Lytix Biopharma AS Main Business and Markets Served
7.1.5 Lytix Biopharma AS Recent Developments/Updates
7.2 Genscript
7.2.1 Genscript Antibacterial Active Peptide Corporation Information
7.2.2 Genscript Antibacterial Active Peptide Product Portfolio
7.2.3 Genscript Antibacterial Active Peptide Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Genscript Main Business and Markets Served
7.2.5 Genscript Recent Developments/Updates
7.3 Biosynth Carbosynth
7.3.1 Biosynth Carbosynth Antibacterial Active Peptide Corporation Information
7.3.2 Biosynth Carbosynth Antibacterial Active Peptide Product Portfolio
7.3.3 Biosynth Carbosynth Antibacterial Active Peptide Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Biosynth Carbosynth Main Business and Markets Served
7.3.5 Biosynth Carbosynth Recent Developments/Updates
7.4 CPC Scientific
7.4.1 CPC Scientific Antibacterial Active Peptide Corporation Information
7.4.2 CPC Scientific Antibacterial Active Peptide Product Portfolio
7.4.3 CPC Scientific Antibacterial Active Peptide Production, Value, Price and Gross Margin (2019-2024)
7.4.4 CPC Scientific Main Business and Markets Served
7.4.5 CPC Scientific Recent Developments/Updates
7.5 Peptilogics, Inc.
7.5.1 Peptilogics, Inc. Antibacterial Active Peptide Corporation Information
7.5.2 Peptilogics, Inc. Antibacterial Active Peptide Product Portfolio
7.5.3 Peptilogics, Inc. Antibacterial Active Peptide Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Peptilogics, Inc. Main Business and Markets Served
7.5.5 Peptilogics, Inc. Recent Developments/Updates
7.6 MaxWell Biosciences
7.6.1 MaxWell Biosciences Antibacterial Active Peptide Corporation Information
7.6.2 MaxWell Biosciences Antibacterial Active Peptide Product Portfolio
7.6.3 MaxWell Biosciences Antibacterial Active Peptide Production, Value, Price and Gross Margin (2019-2024)
7.6.4 MaxWell Biosciences Main Business and Markets Served
7.6.5 MaxWell Biosciences Recent Developments/Updates
7.7 ContraFect Corporation
7.7.1 ContraFect Corporation Antibacterial Active Peptide Corporation Information
7.7.2 ContraFect Corporation Antibacterial Active Peptide Product Portfolio
7.7.3 ContraFect Corporation Antibacterial Active Peptide Production, Value, Price and Gross Margin (2019-2024)
7.7.4 ContraFect Corporation Main Business and Markets Served
7.7.5 ContraFect Corporation Recent Developments/Updates
7.8 Lytica Therapeutics , Inc.
7.8.1 Lytica Therapeutics , Inc. Antibacterial Active Peptide Corporation Information
7.8.2 Lytica Therapeutics , Inc. Antibacterial Active Peptide Product Portfolio
7.8.3 Lytica Therapeutics , Inc. Antibacterial Active Peptide Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Lytica Therapeutics , Inc. Main Business and Markets Served
7.7.5 Lytica Therapeutics , Inc. Recent Developments/Updates
7.9 Amprologix
7.9.1 Amprologix Antibacterial Active Peptide Corporation Information
7.9.2 Amprologix Antibacterial Active Peptide Product Portfolio
7.9.3 Amprologix Antibacterial Active Peptide Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Amprologix Main Business and Markets Served
7.9.5 Amprologix Recent Developments/Updates
7.10 Ingenza
7.10.1 Ingenza Antibacterial Active Peptide Corporation Information
7.10.2 Ingenza Antibacterial Active Peptide Product Portfolio
7.10.3 Ingenza Antibacterial Active Peptide Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Ingenza Main Business and Markets Served
7.10.5 Ingenza Recent Developments/Updates
7.11 ReAlta Life Sciences
7.11.1 ReAlta Life Sciences Antibacterial Active Peptide Corporation Information
7.11.2 ReAlta Life Sciences Antibacterial Active Peptide Product Portfolio
7.11.3 ReAlta Life Sciences Antibacterial Active Peptide Production, Value, Price and Gross Margin (2019-2024)
7.11.4 ReAlta Life Sciences Main Business and Markets Served
7.11.5 ReAlta Life Sciences Recent Developments/Updates
7.12 Celdara Medical
7.12.1 Celdara Medical Antibacterial Active Peptide Corporation Information
7.12.2 Celdara Medical Antibacterial Active Peptide Product Portfolio
7.12.3 Celdara Medical Antibacterial Active Peptide Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Celdara Medical Main Business and Markets Served
7.12.5 Celdara Medical Recent Developments/Updates
7.13 Numaferm
7.13.1 Numaferm Antibacterial Active Peptide Corporation Information
7.13.2 Numaferm Antibacterial Active Peptide Product Portfolio
7.13.3 Numaferm Antibacterial Active Peptide Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Numaferm Main Business and Markets Served
7.13.5 Numaferm Recent Developments/Updates
7.14 ALLVIVO VASCULAR, INC.
7.14.1 ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Corporation Information
7.14.2 ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Product Portfolio
7.14.3 ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Production, Value, Price and Gross Margin (2019-2024)
7.14.4 ALLVIVO VASCULAR, INC. Main Business and Markets Served
7.14.5 ALLVIVO VASCULAR, INC. Recent Developments/Updates
7.15 Matrubials
7.15.1 Matrubials Antibacterial Active Peptide Corporation Information
7.15.2 Matrubials Antibacterial Active Peptide Product Portfolio
7.15.3 Matrubials Antibacterial Active Peptide Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Matrubials Main Business and Markets Served
7.15.5 Matrubials Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Antibacterial Active Peptide Industry Chain Analysis
8.2 Antibacterial Active Peptide Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Antibacterial Active Peptide Production Mode & Process
8.4 Antibacterial Active Peptide Sales and Marketing
8.4.1 Antibacterial Active Peptide Sales Channels
8.4.2 Antibacterial Active Peptide Distributors
8.5 Antibacterial Active Peptide Customers
9 Antibacterial Active Peptide Market Dynamics
9.1 Antibacterial Active Peptide Industry Trends
9.2 Antibacterial Active Peptide Market Drivers
9.3 Antibacterial Active Peptide Market Challenges
9.4 Antibacterial Active Peptide Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Antibacterial Active Peptide Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Antibacterial Active Peptide Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Antibacterial Active Peptide Production Capacity (Tons) by Manufacturers in 2023
Table 4. Global Antibacterial Active Peptide Production by Manufacturers (2019-2024) & (Tons)
Table 5. Global Antibacterial Active Peptide Production Market Share by Manufacturers (2019-2024)
Table 6. Global Antibacterial Active Peptide Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Antibacterial Active Peptide Production Value Share by Manufacturers (2019-2024)
Table 8. Global Antibacterial Active Peptide Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibacterial Active Peptide as of 2023)
Table 10. Global Market Antibacterial Active Peptide Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Antibacterial Active Peptide Production Sites and Area Served
Table 12. Manufacturers Antibacterial Active Peptide Product Types
Table 13. Global Antibacterial Active Peptide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Antibacterial Active Peptide Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Antibacterial Active Peptide Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Antibacterial Active Peptide Production Value Market Share by Region (2019-2024)
Table 18. Global Antibacterial Active Peptide Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Antibacterial Active Peptide Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Antibacterial Active Peptide Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Table 21. Global Antibacterial Active Peptide Production (Tons) by Region (2019-2024)
Table 22. Global Antibacterial Active Peptide Production Market Share by Region (2019-2024)
Table 23. Global Antibacterial Active Peptide Production (Tons) Forecast by Region (2025-2030)
Table 24. Global Antibacterial Active Peptide Production Market Share Forecast by Region (2025-2030)
Table 25. Global Antibacterial Active Peptide Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Antibacterial Active Peptide Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Antibacterial Active Peptide Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 28. Global Antibacterial Active Peptide Consumption by Region (2019-2024) & (Tons)
Table 29. Global Antibacterial Active Peptide Consumption Market Share by Region (2019-2024)
Table 30. Global Antibacterial Active Peptide Forecasted Consumption by Region (2025-2030) & (Tons)
Table 31. Global Antibacterial Active Peptide Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Antibacterial Active Peptide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 33. North America Antibacterial Active Peptide Consumption by Country (2019-2024) & (Tons)
Table 34. North America Antibacterial Active Peptide Consumption by Country (2025-2030) & (Tons)
Table 35. Europe Antibacterial Active Peptide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 36. Europe Antibacterial Active Peptide Consumption by Country (2019-2024) & (Tons)
Table 37. Europe Antibacterial Active Peptide Consumption by Country (2025-2030) & (Tons)
Table 38. Asia Pacific Antibacterial Active Peptide Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 39. Asia Pacific Antibacterial Active Peptide Consumption by Region (2019-2024) & (Tons)
Table 40. Asia Pacific Antibacterial Active Peptide Consumption by Region (2025-2030) & (Tons)
Table 41. Latin America, Middle East & Africa Antibacterial Active Peptide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 42. Latin America, Middle East & Africa Antibacterial Active Peptide Consumption by Country (2019-2024) & (Tons)
Table 43. Latin America, Middle East & Africa Antibacterial Active Peptide Consumption by Country (2025-2030) & (Tons)
Table 44. Global Antibacterial Active Peptide Production (Tons) by Type (2019-2024)
Table 45. Global Antibacterial Active Peptide Production (Tons) by Type (2025-2030)
Table 46. Global Antibacterial Active Peptide Production Market Share by Type (2019-2024)
Table 47. Global Antibacterial Active Peptide Production Market Share by Type (2025-2030)
Table 48. Global Antibacterial Active Peptide Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Antibacterial Active Peptide Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Antibacterial Active Peptide Production Value Share by Type (2019-2024)
Table 51. Global Antibacterial Active Peptide Production Value Share by Type (2025-2030)
Table 52. Global Antibacterial Active Peptide Price (US$/Ton) by Type (2019-2024)
Table 53. Global Antibacterial Active Peptide Price (US$/Ton) by Type (2025-2030)
Table 54. Global Antibacterial Active Peptide Production (Tons) by Application (2019-2024)
Table 55. Global Antibacterial Active Peptide Production (Tons) by Application (2025-2030)
Table 56. Global Antibacterial Active Peptide Production Market Share by Application (2019-2024)
Table 57. Global Antibacterial Active Peptide Production Market Share by Application (2025-2030)
Table 58. Global Antibacterial Active Peptide Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Antibacterial Active Peptide Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Antibacterial Active Peptide Production Value Share by Application (2019-2024)
Table 61. Global Antibacterial Active Peptide Production Value Share by Application (2025-2030)
Table 62. Global Antibacterial Active Peptide Price (US$/Ton) by Application (2019-2024)
Table 63. Global Antibacterial Active Peptide Price (US$/Ton) by Application (2025-2030)
Table 64. Lytix Biopharma AS Antibacterial Active Peptide Corporation Information
Table 65. Lytix Biopharma AS Specification and Application
Table 66. Lytix Biopharma AS Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. Lytix Biopharma AS Main Business and Markets Served
Table 68. Lytix Biopharma AS Recent Developments/Updates
Table 69. Genscript Antibacterial Active Peptide Corporation Information
Table 70. Genscript Specification and Application
Table 71. Genscript Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. Genscript Main Business and Markets Served
Table 73. Genscript Recent Developments/Updates
Table 74. Biosynth Carbosynth Antibacterial Active Peptide Corporation Information
Table 75. Biosynth Carbosynth Specification and Application
Table 76. Biosynth Carbosynth Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Biosynth Carbosynth Main Business and Markets Served
Table 78. Biosynth Carbosynth Recent Developments/Updates
Table 79. CPC Scientific Antibacterial Active Peptide Corporation Information
Table 80. CPC Scientific Specification and Application
Table 81. CPC Scientific Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. CPC Scientific Main Business and Markets Served
Table 83. CPC Scientific Recent Developments/Updates
Table 84. Peptilogics, Inc. Antibacterial Active Peptide Corporation Information
Table 85. Peptilogics, Inc. Specification and Application
Table 86. Peptilogics, Inc. Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Peptilogics, Inc. Main Business and Markets Served
Table 88. Peptilogics, Inc. Recent Developments/Updates
Table 89. MaxWell Biosciences Antibacterial Active Peptide Corporation Information
Table 90. MaxWell Biosciences Specification and Application
Table 91. MaxWell Biosciences Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. MaxWell Biosciences Main Business and Markets Served
Table 93. MaxWell Biosciences Recent Developments/Updates
Table 94. ContraFect Corporation Antibacterial Active Peptide Corporation Information
Table 95. ContraFect Corporation Specification and Application
Table 96. ContraFect Corporation Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. ContraFect Corporation Main Business and Markets Served
Table 98. ContraFect Corporation Recent Developments/Updates
Table 99. Lytica Therapeutics , Inc. Antibacterial Active Peptide Corporation Information
Table 100. Lytica Therapeutics , Inc. Specification and Application
Table 101. Lytica Therapeutics , Inc. Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. Lytica Therapeutics , Inc. Main Business and Markets Served
Table 103. Lytica Therapeutics , Inc. Recent Developments/Updates
Table 104. Amprologix Antibacterial Active Peptide Corporation Information
Table 105. Amprologix Specification and Application
Table 106. Amprologix Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 107. Amprologix Main Business and Markets Served
Table 108. Amprologix Recent Developments/Updates
Table 109. Ingenza Antibacterial Active Peptide Corporation Information
Table 110. Ingenza Specification and Application
Table 111. Ingenza Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 112. Ingenza Main Business and Markets Served
Table 113. Ingenza Recent Developments/Updates
Table 114. ReAlta Life Sciences Antibacterial Active Peptide Corporation Information
Table 115. ReAlta Life Sciences Specification and Application
Table 116. ReAlta Life Sciences Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 117. ReAlta Life Sciences Main Business and Markets Served
Table 118. ReAlta Life Sciences Recent Developments/Updates
Table 119. Celdara Medical Antibacterial Active Peptide Corporation Information
Table 120. Celdara Medical Specification and Application
Table 121. Celdara Medical Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 122. Celdara Medical Main Business and Markets Served
Table 123. Celdara Medical Recent Developments/Updates
Table 124. Numaferm Antibacterial Active Peptide Corporation Information
Table 125. Numaferm Specification and Application
Table 126. Numaferm Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 127. Numaferm Main Business and Markets Served
Table 128. Numaferm Recent Developments/Updates
Table 129. ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Corporation Information
Table 130. ALLVIVO VASCULAR, INC. Specification and Application
Table 131. ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 132. ALLVIVO VASCULAR, INC. Main Business and Markets Served
Table 133. ALLVIVO VASCULAR, INC. Recent Developments/Updates
Table 134. ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Corporation Information
Table 135. Matrubials Specification and Application
Table 136. Matrubials Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 137. Matrubials Main Business and Markets Served
Table 138. Matrubials Recent Developments/Updates
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Antibacterial Active Peptide Distributors List
Table 142. Antibacterial Active Peptide Customers List
Table 143. Antibacterial Active Peptide Market Trends
Table 144. Antibacterial Active Peptide Market Drivers
Table 145. Antibacterial Active Peptide Market Challenges
Table 146. Antibacterial Active Peptide Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antibacterial Active Peptide
Figure 2. Global Antibacterial Active Peptide Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Antibacterial Active Peptide Market Share by Type: 2023 VS 2030
Figure 4. Microbial Antimicrobial Peptides Product Picture
Figure 5. Plant Antimicrobial Peptides Product Picture
Figure 6. Animal Antimicrobial Peptides Product Picture
Figure 7. Others Product Picture
Figure 8. Global Antibacterial Active Peptide Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 9. Global Antibacterial Active Peptide Market Share by Application: 2023 VS 2030
Figure 10. Food
Figure 11. Medical
Figure 12. Animal Food
Figure 13. Others
Figure 14. Global Antibacterial Active Peptide Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Antibacterial Active Peptide Production Value (US$ Million) & (2019-2030)
Figure 16. Global Antibacterial Active Peptide Production Capacity (Tons) & (2019-2030)
Figure 17. Global Antibacterial Active Peptide Production (Tons) & (2019-2030)
Figure 18. Global Antibacterial Active Peptide Average Price (US$/Ton) & (2019-2030)
Figure 19. Antibacterial Active Peptide Report Years Considered
Figure 20. Antibacterial Active Peptide Production Share by Manufacturers in 2023
Figure 21. Antibacterial Active Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. The Global 5 and 10 Largest Players: Market Share by Antibacterial Active Peptide Revenue in 2023
Figure 23. Global Antibacterial Active Peptide Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 24. Global Antibacterial Active Peptide Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 25. Global Antibacterial Active Peptide Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 26. Global Antibacterial Active Peptide Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 27. North America Antibacterial Active Peptide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. Europe Antibacterial Active Peptide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 29. China Antibacterial Active Peptide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 30. Japan Antibacterial Active Peptide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 31. Global Antibacterial Active Peptide Consumption by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 32. Global Antibacterial Active Peptide Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 33. North America Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 34. North America Antibacterial Active Peptide Consumption Market Share by Country (2019-2030)
Figure 35. Canada Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 36. U.S. Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 37. Europe Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 38. Europe Antibacterial Active Peptide Consumption Market Share by Country (2019-2030)
Figure 39. Germany Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 40. France Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 41. U.K. Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 42. Italy Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 43. Russia Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 44. Asia Pacific Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 45. Asia Pacific Antibacterial Active Peptide Consumption Market Share by Regions (2019-2030)
Figure 46. China Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 47. Japan Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 48. South Korea Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 49. China Taiwan Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 50. Southeast Asia Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 51. India Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 52. Latin America, Middle East & Africa Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 53. Latin America, Middle East & Africa Antibacterial Active Peptide Consumption Market Share by Country (2019-2030)
Figure 54. Mexico Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 55. Brazil Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 56. Turkey Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 57. GCC Countries Antibacterial Active Peptide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 58. Global Production Market Share of Antibacterial Active Peptide by Type (2019-2030)
Figure 59. Global Production Value Market Share of Antibacterial Active Peptide by Type (2019-2030)
Figure 60. Global Antibacterial Active Peptide Price (US$/Ton) by Type (2019-2030)
Figure 61. Global Production Market Share of Antibacterial Active Peptide by Application (2019-2030)
Figure 62. Global Production Value Market Share of Antibacterial Active Peptide by Application (2019-2030)
Figure 63. Global Antibacterial Active Peptide Price (US$/Ton) by Application (2019-2030)
Figure 64. Antibacterial Active Peptide Value Chain
Figure 65. Antibacterial Active Peptide Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
